I have the system up and running this early morning and it is scanning through thousands of stocks as I sit here and sip my coffee.. this is amazing to watch. Now I have signed some disclaimers that I did not read and I do not think I am allowed to tell you the Stock Buy recommendations of my new scanning software but I already broke the rules with Bluebird....
and I see the 2nd stock the system is rating a buy is also a biotech and one we have owned before...
So I don't see the huge crime in telling you: No 2 says Buy ABBV!
There is a nice feature with my new software package - the " why " button this gives a concise reason for buying. With BLUE it was "impending takeout". And With ABBV it's:
AbbVie
AbbVie's (NYSE:
ABBV) Lupron Depot (leuprolide acetate), a gonadotropin releasing hormone, is approved for both advanced prostate cancer and endometriosis.
In Q4 2021, the company's Lupron franchise brought in
$192M globally.
In January, research and advisory company Technavio said that the global leuprolide acetate market is
expected to grow by ~$1B from 2021 to 2026 and achieve a ~10.4% year-over-year growth rate in 2022.
No 2's STOCKS TO BUY FOR OCT RALLY-
BLUE-
ABBV-
Unfortunately I can only access one buy per day on the plan that I signed up for... so BLUE was on Friday and ABBV today. Sunday I will ask again!